Final NHS nod for Allergan’s Ozurdex, AbbVie’s Humira in uveitis

27th July 2017 Uncategorised 0

Cost regulators for NHS treatments in England and Wales have deemed AbbVie’s Humira and Allergan’s Ozurdex clinically and cost effective for treating adults with certain types of non-infectious uveitis who have had an inadequate response to corticosteroids.

More: Final NHS nod for Allergan’s Ozurdex, AbbVie’s Humira in uveitis
Source: News